Skip to content
Current Liabilities

Accrued Expenses

Medtronic Accrued Expenses increased by 3.7% to $3.63B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.3%, from $3.68B to $3.63B. Over 5 years (FY 2021 to FY 2026), Accrued Expenses shows relatively stable performance with a 0.9% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2015
Last reportedQ4 2026Jun 18, 2026

How to read this metric

An increase in accrued expenses may indicate rising operational activity or a strategic decision to delay cash outflows, while a significant decrease could signal the settlement of obligations or a reduction in operational accruals. Rapid growth relative to revenue may suggest potential liquidity pressure or changes in payment terms with vendors and employees.

Detailed definition

Accrued expenses represent liabilities for goods or services that have been received or consumed by the company but for...

Peer comparison

Peer medical device companies typically maintain similar accrual patterns based on their payroll cycles, tax obligations, and R&D spending intensity; significant deviations from industry norms often warrant investigation into accounting policy changes or shifts in working capital management.

Metric ID: accrued_expenses

Historical Data

21 periods
 Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Value$3.48B$3.65B$3.47B$3.54B$3.55B$3.82B$4.03B$3.63B$3.58B$3.58B$3.3B$3.49B$3.58B$3.6B$3.26B$3.53B$3.68B$3.6B$3.15B$3.5B$3.63B
QoQ Change+5.1%-5.0%+2.1%+0.3%+7.5%+5.6%-9.9%-1.3%+0.0%-7.9%+5.7%+2.7%+0.6%-9.5%+8.2%+4.5%-2.4%-12.3%+11.1%+3.7%
YoY Change+2.2%+4.5%+16.2%+2.5%+0.8%-6.2%-18.2%-3.9%+0.0%+0.6%-1.2%+1.1%+2.8%-0.2%-3.3%-0.6%-1.3%
Range$3.15B$4.03B
CAGR+0.9%
Avg YoY Growth-0.2%
Median YoY Growth+0.0%
Current Streak2 quarters growth

Frequently Asked Questions

What is Medtronic's accrued expenses?
Medtronic (MDT) reported accrued expenses of $3.63B in Q1 2026.
How has Medtronic's accrued expenses changed year-over-year?
Medtronic's accrued expenses decreased by 1.3% year-over-year, from $3.68B to $3.63B.
What is the long-term trend for Medtronic's accrued expenses?
Over 5 years (2021 to 2026), Medtronic's accrued expenses has grown at a 0.9% compound annual growth rate (CAGR), from $3.48B to $3.63B.
What does accrued expenses mean?
Accrued expenses are costs the company has incurred but has not yet paid for.